Profile data is unavailable for this security.
About the company
OrthoPediatrics Corp. is an orthopedic company, which is focused on advancing the field of pediatric orthopedics. The Company is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. It markets 80 surgical and specialized bracing systems.
- Revenue in USD (TTM)227.41m
- Net income in USD-45.61m
- Incorporated2007
- Employees562.00
- LocationOrthoPediatrics Corp2850 Frontier DriveWARSAW 46582United StatesUSA
- Phone+1 (302) 658-7581
- Fax+1 (302) 655-5049
- Websitehttps://www.orthopediatrics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Delcath Systems Inc | 79.60m | 1.20m | 328.77m | 96.00 | 1,070.12 | 2.86 | 235.85 | 4.13 | 0.0087 | 0.0087 | 2.10 | 3.25 | 1.02 | 1.26 | 7.70 | 829,197.90 | 1.54 | -94.54 | 1.90 | -143.97 | 86.29 | 81.31 | 1.50 | -339.85 | 13.71 | -- | 0.00 | -- | 1,701.70 | 88.10 | 44.66 | -- | 87.69 | -- |
| Rxsight Inc | 142.09m | -35.73m | 330.58m | 498.00 | -- | 1.20 | -- | 2.33 | -0.8782 | -0.8782 | 3.50 | 6.72 | 0.4591 | 1.40 | 5.74 | 285,313.30 | -11.54 | -19.50 | -12.45 | -21.50 | 74.98 | 57.17 | -25.15 | -52.00 | 11.44 | -- | 0.0004 | -- | 57.09 | 128.61 | 43.52 | -- | 5.89 | -- |
| Clearpoint Neuro Inc | 34.33m | -23.14m | 403.09m | 115.00 | -- | 24.27 | -- | 11.74 | -0.8264 | -0.8264 | 1.23 | 0.5584 | 0.6829 | 1.95 | 7.52 | 298,539.10 | -46.03 | -35.94 | -54.48 | -41.48 | 61.31 | 63.49 | -67.40 | -74.87 | 5.56 | -92.37 | 0.6479 | -- | 31.04 | 22.85 | 14.37 | -- | 11.41 | -- |
| Myriad Genetics Inc | 825.30m | -400.50m | 418.53m | 2.70k | -- | 1.12 | -- | 0.5071 | -4.34 | -4.34 | 8.97 | 4.00 | 0.9122 | 8.46 | 6.77 | 305,666.70 | -44.27 | -- | -53.15 | -- | 70.36 | -- | -48.53 | -- | 2.12 | -14.93 | 0.2427 | -- | 11.21 | -- | 51.65 | -- | -- | -- |
| Orthopediatrics Corp | 227.41m | -45.61m | 423.56m | 562.00 | -- | 1.21 | -- | 1.86 | -1.96 | -1.96 | 9.74 | 13.93 | 0.4628 | 0.5149 | 4.83 | 404,644.10 | -9.28 | -5.87 | -9.97 | -6.44 | 71.73 | 74.27 | -20.06 | -16.55 | 3.52 | -5.96 | 0.2214 | -- | 37.65 | 23.06 | -80.33 | -- | 4.29 | -- |
| Cerus Corp | 225.97m | -15.96m | 430.28m | 281.00 | -- | 7.00 | -- | 1.90 | -0.0848 | -0.0848 | 1.20 | 0.3201 | 1.12 | 1.99 | 8.35 | 804,163.70 | -7.91 | -20.38 | -12.30 | -31.96 | 60.50 | 61.15 | -7.09 | -25.37 | 1.29 | -1.04 | 0.5772 | -- | 7.78 | 16.51 | 44.20 | -- | -20.50 | -- |
| Standard Biotools Inc | 128.83m | -109.46m | 430.71m | 818.00 | -- | 1.08 | -- | 3.34 | -0.289 | -0.3383 | 0.3399 | 1.04 | 0.211 | 1.97 | 5.27 | 157,490.20 | -17.93 | -29.45 | -22.06 | -35.68 | 47.94 | 50.11 | -84.97 | -79.68 | 4.14 | -- | 0.0008 | -- | 64.03 | 8.27 | -147.67 | -- | 26.98 | -- |
| AngioDynamics, Inc. | 307.31m | -27.71m | 452.15m | 675.00 | -- | 2.59 | -- | 1.47 | -0.6731 | -0.6731 | 7.47 | 4.24 | 1.10 | 2.12 | 7.02 | 455,268.20 | -9.87 | -13.69 | -13.83 | -16.19 | 54.58 | 52.46 | -9.02 | -21.32 | 1.33 | -- | 0.0329 | -- | -3.76 | 2.06 | 81.56 | -- | -10.06 | -- |
| Neuropace Inc | 94.86m | -23.99m | 497.88m | 209.00 | -- | 27.05 | -- | 5.25 | -0.7535 | -0.7535 | 2.98 | 0.5564 | 0.9321 | 1.46 | 7.16 | 515,565.20 | -23.57 | -35.71 | -28.36 | -44.34 | 76.77 | 73.39 | -25.28 | -60.45 | 3.94 | -3.58 | 0.7603 | -- | 22.14 | 16.67 | 17.64 | -- | -8.15 | -- |
| Mesa Laboratories Inc | 247.54m | 3.73m | 500.49m | 730.00 | 140.00 | 2.68 | 17.41 | 2.02 | 0.6471 | 0.6471 | 44.81 | 33.79 | 0.5678 | 3.40 | 6.28 | 339,097.30 | 0.8564 | -8.81 | 1.13 | -9.71 | 62.40 | 61.98 | 1.51 | -25.15 | 1.45 | 1.62 | 0.4709 | -- | 11.47 | 15.41 | 99.22 | -- | 24.60 | 0.00 |
| Pacific Biosciences of California Inc | 160.01m | -546.38m | 516.26m | 575.00 | -- | 96.52 | -- | 3.23 | -1.84 | -1.84 | 0.5335 | 0.0177 | 0.1565 | 1.96 | 5.08 | -- | -53.45 | -22.47 | -59.23 | -24.40 | 33.97 | 33.11 | -341.47 | -214.45 | 2.44 | -19.72 | 0.9918 | -- | 3.89 | 15.19 | -76.34 | -- | -- | -- |
| Anteris Technologies Global Corp | 2.14m | -84.32m | 523.69m | 136.00 | -- | 55.68 | -- | 244.82 | -2.34 | -2.34 | 0.0594 | 0.1025 | 0.1065 | 1.53 | 11.88 | 15,728.75 | -420.16 | -- | -1,527.00 | -- | 67.94 | -- | -3,945.70 | -- | 0.8032 | -- | 0.046 | -- | -1.16 | -- | -65.77 | -- | -- | -- |
| Orthofix Medical Inc | 818.06m | -119.12m | 529.84m | 1.62k | -- | 1.19 | -- | 0.6477 | -3.04 | -3.04 | 20.82 | 11.20 | 0.9622 | 1.37 | 6.40 | 506,224.00 | -14.01 | -10.81 | -17.28 | -13.34 | 68.27 | 70.31 | -14.56 | -11.57 | 1.38 | -1.35 | 0.2837 | -- | 7.08 | 11.69 | 16.78 | -- | 8.75 | -- |
Data as of Feb 13 2026. Currency figures normalised to OrthoPediatrics Corp's reporting currency: US Dollar USD
43.30%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Brown Advisory LLCas of 31 Dec 2025 | 1.89m | 7.54% |
| Millennium Management LLCas of 29 Oct 2025 | 1.39m | 5.55% |
| Morgan Stanley & Co. LLCas of 31 Dec 2025 | 1.11m | 4.42% |
| Braidwell LPas of 30 Sep 2025 | 1.11m | 4.42% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 1.08m | 4.32% |
| Brown Capital Management LLCas of 30 Sep 2025 | 1.08m | 4.31% |
| Wellington Management Co. LLPas of 30 Sep 2025 | 994.55k | 3.97% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 853.90k | 3.41% |
| Granahan Investment Management, LLCas of 30 Sep 2025 | 759.95k | 3.03% |
| Dimensional Fund Advisors LPas of 31 Dec 2025 | 589.92k | 2.35% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
